Driss Oraichi

5PUBLICATIONS
21CO-AUTHORS
Disease surveillanceEpidemiological methodsOccupational epidemiologyPreventative health carePacific Peoples epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 10, 2026
Age-specific Risk of Herpes Zoster in Immunocompetent Adults ≥18 Years-of-age-A Retrospective Cohort Study in the United States.

Rachel A Cohen, Driss Oraichi, Agnes Mwakingwe-Omari

|Mar 26, 2026
Age-Specific Risk of Herpes Zoster in Adults Aged ≥18 Years With Comorbid Conditions-A Retrospective Cohort Study in the United States.

Rachel A Cohen, Driss Oraichi, Agnes Mwakingwe-Omari

|Aug 12, 2025
Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years.

Emily Rayens, Lina S Sy, Lei Qian

|Jun 28, 2025
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States.

Hung-Fu Tseng, Lina S Sy, Bradley K Ackerson

Pageof 1